Alterations of Bone Metabolism in Patients with Diabetes Mellitus

Table 2

Characteristics of calcium-regulating hormones, bone markers, and BMD values.

Variables	DM1 (n = 98)	DM2 (n = 137)	Control (n = 82)
PTH, ng/L	51.16 (47.17–55.13)	51.69 (48.82–54.56)	45.09 (40.38–49.79)
CT, ng/L	12.07 (9.75–14.38)	10.23 (8.48–11.62)	5.5 (4.19–6.84)
25 (OH) D, nmol/L	60.12 (53.21–67.04)	62.69 (57.35–68.08)	75.9 (67.26–84.51)
ALP, IU/L	118.3 (110.1–126.4)	122.2 (116.2–128.1)	123.5 (113.8–133.2)
P1NP, ng/mL	40.58 (37.18–43.98)	42.08 (39.81–44.35)	47.09 (42.82–51.35)
b-CTX, ng/mL	0.525 (0.468–0.582)	0.495 (0.456–0.533)	0.424 (0.383–0.466)
Т-score (L1–L4)	−2.04 (−2.3; −1.7)	−1.08 (−1.3; −0.8)	−0.73 (−1.1; −0.3)
Т-score (prox.)	−1.44 (−1.7; −1.1)	−0.95 (−1.2; −0.7)	−0.49 (−0.8; −0.1)
Т-score (FN)	−1.68 (−1.9; −1.3)	−1.12 (−1.3; −0.8)	−0.64 (−1.0; −0.2)

compared with the control group data.